| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| INVESTMENT IN BUSINESS VALUE PARTNERS | AT COST | 863,734 | 863,734 |
| CAAS PHARMACEUTICALS | AT COST | 7,000 | 7,000 |
| NOTABLE LABS LTD | AT COST | 1 | 1 |
| Description | Amount |
|---|---|
| UNREALIZED GAIN/LOSS ON APPRECIATION | 215,792 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| OTHER DEDUCTIONS | 8,819 | 8,819 | 0 | 0 |
| MISCELLANEOUS EXPENSE | 82 | 82 | 0 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| BUSINESS VALUE PARTNERS OTHER INCOME | 577 | 577 | 577 |
| BUSINESS VALUE PARTNERS ORDINARY INCOME | -250 | -250 | -250 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| AUDIT EXPENSE | 2,040 | 0 | 0 | 0 |